Simplex Trading
IOVA icon

Simplex Trading’s Iovance Biotherapeutics IOVA Stock Holding History

Simplex Trading’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Buy
424,300
+84,700
+25% +$271K ﹤0.01% 2090
2025
Q4 		$927K Buy
339,600
+89,200
+36% +$206K ﹤0.01% 2700
2025
Q3 		$543K Buy
250,400
+8,600
+4% +$20.3K ﹤0.01% 3718
2025
Q2 		$415K Buy
241,800
+82,300
+52% +$205K ﹤0.01% 3711
2025
Q1 		$531K Sell
159,500
-291,300
-65% -$1.5M ﹤0.01% 3338
2024
Q4 		$3.33M Buy
450,800
+81,100
+22% +$752K ﹤0.01% 1774
2024
Q3 		$3.47M Buy
369,700
+73,700
+25% +$698K ﹤0.01% 1801
2024
Q2 		$2.37M Buy
296,000
+71,500
+32% +$766K ﹤0.01% 2043
2024
Q1 		$3.33M Sell
224,500
-124,200
-36% -$1.45M ﹤0.01% 1939
2023
Q4 		$2.83M Buy
348,700
+56,700
+19% +$297K ﹤0.01% 2058
2023
Q3 		$1.33M Buy
292,000
+239,500
+456% +$1.56M ﹤0.01% 2417
2023
Q2 		$369K Buy
52,500
+8,200
+19% +$58.7K ﹤0.01% 3619
2023
Q1 		$270K Buy
44,300
+13,400
+43% +$92.5K ﹤0.01% 3962
2022
Q4 		$197K Buy
30,900
+26,200
+557% +$205K ﹤0.01% 4250
2022
Q3 		$45K Sell
4,700
-31,300
-87% -$361K ﹤0.01% 6592
2022
Q2 		$397K Buy
36,000
+25,000
+227% +$328K ﹤0.01% 3737
2022
Q1 		$183K Sell
11,000
-15,300
-58% -$237K ﹤0.01% 5286
2021
Q4 		$502K Buy
26,300
+7,000
+36% +$154K ﹤0.01% 3805
2021
Q3 		$512K Buy
19,300
+300
+2% +$7.07K ﹤0.01% 4075
2021
Q2 		$494K Buy
+19,000
New +$494K ﹤0.01% 4192
2021
Q1 		– Sell
-234
Closed -$1.08M – 9358
2020
Q4 		$1.08M Buy
234
+182
+350% +$7.23K ﹤0.01% 2448
2020
Q3 		$171K Sell
52
-34
-40% -$1.04K ﹤0.01% 4303
2020
Q2 		$236K Sell
86
-200
-70% -$6.58K ﹤0.01% 3810
2020
Q1 		$856K Buy
286
+28
+11% +$742 ﹤0.01% 2023
2019
Q4 		$714K Sell
258
-28
-10% -$637 ﹤0.01% 2393
2019
Q3 		$520K Buy
286
+259
+959% +$5.73K ﹤0.01% 2578
2019
Q2 		$66K Buy
+27
New +$407 ﹤0.01% 4599
2019
Q1 		– Sell
-10
Closed -$8K – 7440
2018
Q4 		$8K Sell
10
-50
-83% -$482 ﹤0.01% 5974
2018
Q3 		$67K Buy
60
+45
+300% +$639 ﹤0.01% 4866
2018
Q2 		$19K Sell
15
-37
-71% -$541 ﹤0.01% 5900
2018
Q1 		$19K Buy
52
+10
+24% +$151 ﹤0.01% 3414
2017
Q4 		$6K Buy
42
+4
+11% +$32 ﹤0.01% 4336
2017
Q3 		$1K Buy
38
+28
+280% +$177 ﹤0.01% 5455
2017
Q2 		$1K Hold
10
– – ﹤0.01% 5627
2017
Q1 		$2K Sell
10
-528
-98% -$3.87K ﹤0.01% 5271
2016
Q4 		$40K Sell
538
-223
-29% -$1.53K ﹤0.01% 2377
2016
Q3 		$54K Sell
761
-1,831
-71% -$15.5K ﹤0.01% 2033
2016
Q2 		$155K Buy
+2,592
New +$16.3K 0.01% 1167
2015
Q4 		– Sell
-100
Closed -$18K – 5721
2015
Q3 		$18K Buy
+100
New +$779 ﹤0.01% 2899

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Simplex Trading's IOVA Position: Q1 2026 in Review

Simplex Trading reduced its Iovance Biotherapeutics (IOVA) stake by 54% in Q1 2026, selling an estimated $567K and leaving 151,831 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #3177.

Simplex Trading first reported a position in IOVA in Q3 2015 and has held it in 33 quarters since. The position peaked at $3.04M in Q4 2023. 285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Simplex Trading held 151,831 shares of Iovance Biotherapeutics worth $533K as of Q1 2026.
  • Simplex Trading sold 177,232 Iovance Biotherapeutics shares in Q1 2026, an estimated $567K.
  • Iovance Biotherapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3177 holding.
  • Simplex Trading first reported a position in Iovance Biotherapeutics in Q3 2015 and has held it in 33 quarters since.
  • Simplex Trading's Iovance Biotherapeutics position peaked at $3.04M in Q4 2023.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.